rejuvant life tabs
rejuvant life tabs

Biotech

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

BioAge licenses Amgen drug to treat muscle aging

Exclusive deal to develop and commercialise Amgen’s Phase 1 APJ agonist, after BioAge platform identifies its potential in promoting longevity and reducing symptoms of...

Latest news

BioAge licenses Amgen drug to treat muscle aging

Exclusive deal to develop and commercialise Amgen’s Phase 1 APJ agonist, after BioAge platform identifies its potential in promoting longevity and reducing symptoms of...

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...

Targeting mitochondria to beat hair loss and skin wrinkles

Yuva Biosciences gears up for human trials of cosmeceutical treatments that target mitochondrial dysfunction. With an initial focus on developing cosmeceuticals, US start-up Yuva Biosciences...

HitGen and BioAge progress drug discovery collaboration

Companies announce research progress in DNA-encoded library-based drug discovery research collaboration. Shanghai Stock Exchange-listed biotech HitGen, Inc announced important research progress in a collaboration with...

Nerve regeneration tech targets Alzheimer’s and Nasdaq

NervGen readies for NASDAQ listing and clinical trials of lead compound for nerve regeneration in 2021. With a unique nerve regeneration technology, Canadian biotech NervGen...

ITP lifespan extension study: more NAD+ research

ITP lifespan extension study brings mixed bag of results for longevity drugs. The long-awaited results of the National Institute on Aging Interventions Testing Program's look...

CBD improves cognition in Alzheimer’s model

High doses of cannabidiol restores protein function to reduce beta-amyloid plaques in Alzheimer's. Alzheimer’s disease is a neurodegenerative disease that causes beta-amyloid plaques to build...

Metformin: a longevity drug for men only?

Researchers give new insights into metformin's life-extending effects, but is it just drugs for the boys? Life expectancy has increased in the past few years...

Longevity pharmacology “promises to revolutionize medicine”

Leading biogerontologist João Pedro de Magalhães says that longevity pharmacology has come of age, and discusses rapamycin, Calico and human trials. The longevity space is...
Rejuvant
Supps report ad middle

Cambrian Biopharma – CEO James Peyer Q&A

Longevity biotech exclusive Q&A with Cambrian Biopharma's CEO – hallmarks of aging and classifying aging as a disease. Dr James Peyer is Cambrian's CEO and...

Open platform to democratise longevity therapeutics R&D

VitaDAO aims to extend human lifespan “by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.” An interesting new player has just...

BioAge’s Phase 2 trial to reverse immune aging

Following compelling animal model data, BGE-175 to be used to treat COVID-19 in older patients by reversing immune aging. Fresh from announcing a clinical trial...

Longevity biotech announces phase 2 mitochondrial study

Study will evaluate efficacy of first-in-class, oral drug candidate in patients with the devastating neurodegenerative disease ALS. Retrotope, a clinical-stage biopharmaceutical company focused on the...

Most popular

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

NAD+ and metformin: AgelessRx’s anti-aging platform

Personalised longevity medicine is the top goal for AgelessRx. In November we spoke to Anar Isman, the Co-founder & CEO of AgelessRx, about PEARL, the...

It’s time to sit up and take notice of mitochondria

CohBar CEO on the development of a “true portfolio” of mitochondria based therapeutics. US biotech company CohBar is developing mitochondria-based therapeutics for the treatment of...
Supplement report

You might also like

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained. Since the discovery...
Supps report ad middle